2019
DOI: 10.2147/ott.s191414
|View full text |Cite
|
Sign up to set email alerts
|

<p>The expression of special AT-rich binding protein 1 in cervical cancer and its clinical significance</p>

Abstract: BackgroundThe oncogenic potential of special AT-rich binding protein 1 (SATB1) has been reported in various types of cancer, but its function in cervical cancer remains not fully investigated. This study aimed to investigate the effect of SATB1 mRNA expression on tumor progression and outcomes in the cervical cancer patients.MethodsA total of 33 cervical cancer patients treated in our hospital from September 2012 to December 2015 were included. The mRNA expression level of STAB1 in cervical cancer tissue was d… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 33 publications
0
3
0
Order By: Relevance
“…The malignant behavior of ADC is extremely strong, it has the capability of long-distance transmission, is resistant to radiotherapy and systemic chemotherapy and has a particularly poor prognosis. 7,8 In previous literature, there have been many efforts to enhance the clinicopathological assessment of the predictive prognostic factor of ADC, 2,[9][10][11] such as International Federation of Gynecology and Obstetrics (FIGO) stage, lymph node metastasis (LNM), stromal invasion, differentiation and tumor size. However, the above studies mainly focused on postoperative predictive prognostic factors, lacking preoperative intervention and assessment.…”
Section: Introductionmentioning
confidence: 99%
“…The malignant behavior of ADC is extremely strong, it has the capability of long-distance transmission, is resistant to radiotherapy and systemic chemotherapy and has a particularly poor prognosis. 7,8 In previous literature, there have been many efforts to enhance the clinicopathological assessment of the predictive prognostic factor of ADC, 2,[9][10][11] such as International Federation of Gynecology and Obstetrics (FIGO) stage, lymph node metastasis (LNM), stromal invasion, differentiation and tumor size. However, the above studies mainly focused on postoperative predictive prognostic factors, lacking preoperative intervention and assessment.…”
Section: Introductionmentioning
confidence: 99%
“…This gene is involved in the epithelial-mesenchymal transition [63][64][65][66], and its overexpression has been associated with a worse prognosis in solid tumors [67]. In CC, it was identified as highly expressed in those women who presented advanced stages of the disease and through a Kaplan-Meier analysis, it was possible to associate it as a worse prognosis marker [68].…”
Section: Discussionmentioning
confidence: 99%
“…ARHGDIB and STAT1 are increased in models of breast cancer CTCs ( 50 , 51 ) while STAB1 and TLR2 are increased in tumor-associated inflammatory cells in breast and colorectal cancer ( 52 55 ). Correspondingly increased expression of ARHGDIB ( 56 , 57 ), OLFML2B ( 58 60 ), STAB1 ( 61 ) and TLR2 ( 62 , 63 ) have been associated with disease relapse in most of the same cancers. Notably, STAB1 has been identified as a potential therapeutic target in neuroblastoma to block the tumorigenic effects of osteonectin ( 64 ).…”
Section: Discussionmentioning
confidence: 99%